Tiny pollution particles from smoke, soot, and dust may worsen rheumatoid arthritis and raise the risk of painful flares, particularly after prolonged exposure. The findings suggest that avoiding poor air quality could become an important part of managing the disease.
Air pollution may make rheumatoid arthritis more active and increase the likelihood of painful flare-ups, according to a new study. The strongest connection involved fine particulate matter found in dust, soot, and smoke (PM2.5).
Published in the Annals of the Rheumatic Diseases (ARD), The EULAR Journal, by Elsevier, the findings suggest that air quality may be an important consideration for both healthcare professionals treating rheumatoid arthritis and policymakers working to protect public health.
Rheumatoid arthritis, commonly known as RA, is a chronic autoimmune condition that causes inflammation and damage in the joints. It can also produce widespread symptoms that affect other areas of the body.
The disease affects an estimated 0.5% to 1% of adults worldwide. Its development is influenced by a combination of genetics, changes in immune function, and environmental exposures. Some of these environmental influences may contribute not only to the initial development of RA, but also to worsening symptoms after the disease has been diagnosed.
Importantly, several environmental risk factors can potentially be modified. Smoking is already recognized as a major risk factor. Researchers have also examined the possible effects of temperature, humidity, silica, and other pollutants.
Earlier population studies found that exposure to polluted air was associated with a greater likelihood of developing RA. Researchers in South Korea wanted to determine whether air pollution could also affect disease activity and trigger flares in people who already had the condition. They also investigated the biological processes that might explain such a connection.
In an accompanying editorial Jeffrey A. Sparks, MD, MMSc, Division of Rheumatology, Inflammation, and Immunity, Mass General Brigham / Brigham and Women’s Hospital, and Harvard Medical School, comments, “This is one of the largest studies to use robust methods to link air pollutants with RA disease activity. Considering rising levels of air pollutants, these results have significant clinical, biologic, and public health implications. They also further reinforce that inhalants may have broad implications for risk and progression of RA and perhaps other autoimmune diseases. From a clinical perspective, this may offer avenues to lower the risk of RA flares by avoiding air with poor quality and provide some potential explanation for otherwise idiosyncratic RA flares.”
https://www.sciencedaily.com/releases/2026/08/260805082452.htm
